Announced Mon, 6 Jul · 13:46 IST
Quarterly RTA certificate under SEBI Regulation 74(5) filed
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹190.15
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.8-6.9-3.2-3.8—-5.1-5.3———
Up moveDown movePending
AI summary
Speciality Medicines filed a quarterly certificate from its Registrar Skyline Financial Services under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The RTA confirmed that no physical share certificates were received from depository participants for dematerialization of equity shares during the quarter. Signed by Chairman and MD Parthkumar Goyani on July 6, 2026.
Likely market impact
Routine procedural compliance filing with no material impact on stock price or shareholders. Indicates no pending physical share certificates for dematerialization.